Bitransgenesis with β2-adrenergic receptors or adenylyl cyclase fails to Improve β1-adrenergic receptor cardiomyopathy

Natalia Petrashevskaya, Brigitte R. Gaume, Kathryn A. Mihlbachler, Gerald W. Dorn, Stephen B. Liggett

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Cardiomyopathic effects of β-adrenergic receptor (βAR) signaling are primarily due to the β1 AR subtype. β12 AR and β1/ adenylyl cyclase type 5 (AC5) bitransgenic mice were created to test the hypothesis that β2 AR or AC5 co-overexpression has beneficial effects in β1 AR-mediated cardiomyopathy. In young mice, β12 hearts had a greater increase in basal and isoproterenol-stimulated contractility compared to β1/AC5 and β1 AR hearts. By 6 months, β1 AR and β12 hearts retained elevated basal contractility but were unresponsive to agonist. In contrast, β1/AC5 hearts maintained a small degree of agonist responsiveness, which may be due to a lack of β1 AR downregulation that was noted in β1- and β12hearts. However, by 9-months, β1, β12, and β1/AC5 mice had all developed severely depressed fractional shortening in vivo and little response to agonist. p38 mitogen activated protein kinase (MAPK) was minimally activated by β1AR, but was markedly enhanced in the bitransgenics. Akt activation was only found with the bitransgenics. The small increase in cystosolic second mitochondria-derived activator of caspase (Smac), indicative of apoptosis in 9-month β1AR hearts, was suppressed in β1/AC5, but not in β1/ β2, hearts. Taken together, the unique signaling effects of enhanced β2 AR and AC5, which have the potential to afford benefit in heart failure, failed to salvage ventricular function in β1 AR-mediated cardiomyopathy.

Original languageEnglish
Pages (from-to)221-227
Number of pages7
JournalClinical and translational science
Issue number3
StatePublished - Dec 2008


  • Adenylyl cyclase
  • Apoptosis
  • Heart failure
  • Transgenes
  • β-adrenergic receptors


Dive into the research topics of 'Bitransgenesis with β2-adrenergic receptors or adenylyl cyclase fails to Improve β1-adrenergic receptor cardiomyopathy'. Together they form a unique fingerprint.

Cite this